2 Tower Center Blvd., Suite 1101A
East Brunswick, NJ 08816-1100
Phone: 1.844.227.6687
Fax: 1.732.647.1272
Respiratory tract infections caused by susceptible isolates of Streptococcus pneumoniae and Streptococcus pyogenes.
Otitis media caused by susceptible isolates of Streptococcus pneumoniae, Haemophilus influenzae, Staphylococcus aureus, Streptococcus pyogenes, and Moraxella catarrhalis.
Skin and skin structure infections caused by susceptible isolates of the following Gram-positive bacteria: Staphylococcus aureus and Streptococcus pyogenes.
Bone infections caused by susceptible isolates of Staphylococcus aureus and Proteus mirabilis.
Genitourinary tract infections, including acute prostatitis, caused by susceptible isolates of Escherichia coli, Proteus mirabilis, and Klebsiella pneumoniae.
FDA approved under ANDA 065253, this product has been shown to be bioequivalent to the reference product, Keflex®.
Available in:
• 250 mg and 500 mg capsules in 500 count bottles.
• 100 mg and 200 mg capsules in 100 count bottles.
For more information about Cronus Pharma products please contact your authorized distributor.
1 (844) 227-6687
Cronus Pharma LLC is a fully integrated R&D, manufacturing, and marketing animal health pharmaceutical company located in East Brunswick, New Jersey. Dedicated to providing quality and cost-effective pharmaceuticals to the U.S. animal health market, our products are accessible to all veterinarians and pet owners through national and regional distributors.
Cronus Pharma © 2022 All Rights Reserved. Keflex® is a registered trademark of Eli Lilly and Company.
Please see the additional pages for product information, including caution statements.